The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

计划入组 15 人 · 首次发布于 2021 年 4 月 2 日

The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients

计划入组 10 人 · 首次发布于 2021 年 7 月 15 日

The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin

计划入组 10 人 · 首次发布于 2011 年 9 月 16 日

Transthyretin Amyloidosis Therapy (HuidaGene)

Patisiran(Onpattro)

Rx

Amyloid beta catabody

MYELOID THERAPEUTICS

United States

Amylin Pharmaceuticals, Inc.

United States

EU Approves WAINZUA (Eplontersen) for Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

FDA Approves AstraZeneca and Ionis' Wainua for Hereditary ATTR Polyneuropathy

Antisense Oligonucleotide Therapies Advance in Genetic Medicine